Intellectual Property India Publishes Patent Application for 'Cell-Free Methods Of Producing Antibodies To Intracellular Targets' Filed by Mbrace Therapeutics, Inc.

MUMBAI, India, April 11 -- Intellectual Property India has published a patent application (202517012708 A) filed by Mbrace Therapeutics, Inc., San Diego, on Feb. 14, for 'cell-free methods of producing antibodies to intracellular targets.'

Inventor(s) include Wu, Yongjian; Staquicini, Fernanda I; and Chen, Isan.

The application for the patent was published on April 11, under issue no. 15/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are methods and cell-free systems for production of a recombinant antibody in which the antibody is directed against a target protein that is natively expressed as an intracellular protein. Also provided herein are modified cell-free systems for use in such meth...